Serum tumor marker assessment indicated elevated levels of neuron-specific enolase at 27.22 ng/mL and cytokeratin 19 fragment (Cyfra 21–1) at 3.43 ng/mL, whereas other tumor markers were within the normal ranges. This evidence concerns the gene ENO2 and neoplasm.